Skip to content
Screener

Centene CNC Stock Issuance Proceeds

Stock Issuance Proceeds at other companies

CVS Health logo
CVS HealthCVS
$114M+143%
UnitedHealth Group logo
UnitedHealth GroupUNH
$231M-35.8%
Elevance Health logo
Elevance HealthELV
$26M
Oscar Health logo
Oscar HealthOSCR
$28.77M+22.1%
Astrana Health logo
Astrana HealthASTH
$0-100%
Alignment Healthcare logo
Alignment HealthcareALHC
$2.17M+950%

Other financials

Income statement

See full
Revenue$53.6B+9.9%
Gross profit$52.9B+9.9%
Operating income$1.2B+362%
Net income$1.1B+531%
EPS (diluted)$2.19+529%

Balance sheet

See full
Cash & equivalents$24.2B+66.4%
Total debt$16.1B-8.4%
Total equity$22.6B-17.7%
Total assets$83.0B-3.9%

Cash flow

See full
Operating cash flow$3.6B+101%
CapEx$174.0M-16.3%
Free cash flow$3.4B+117%

Valuation

See full
Market cap$31.71B+156%
Enterprise value$23.67B+53.2%
P/S0.2×+0.1×

Profitability

See full
Gross margin98.6%+0.2pp
Operating margin-2.8%-3.9pp
Net margin-2.5%-3.7pp
FCF margin4.4%+3.8pp

Returns & leverage

See full
Return on equity-20.4%-27.9pp
Debt / equity0.7×+0.1×
Current ratio1.1×0.0×

Where this comes from

Reported directly by Centene in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromIssuanceOfCommonStock.

The source filing: Centene’s 10-Q, filed July 28, 2026.

Filed
Jul 27, 2026, 8:00 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001071739-26-000153
Line itemSix Months Ended June 30, 2026Six Months Ended June 30, 2025
Proceeds from long-term debt750
Payments and repurchases of long-term debt(1,304)(1,707)
Common stock repurchases(33)(473)
Proceeds from common stock issuances1818
Other financing activities, net(3)(12)
Net cash (used in) financing activities(1,322)(1,424)
Net increase in cash, cash equivalents and restricted cash and cash equivalents6,370443
Cash and cash equivalents reclassified (to) held for sale(73)

Item 1. Financial Statements.

FAQ

What is Centene's stock issuance proceeds?
Centene (CNC) reported stock issuance proceeds of $8M in Q2 2026.
How has Centene's stock issuance proceeds changed year-over-year?
Centene's stock issuance proceeds decreased by 0.0% year-over-year, from $8M to $8M.
What is the long-term trend for Centene's stock issuance proceeds?
Over 4 years (2021 to 2025), Centene's stock issuance proceeds has grown at a 1.4% compound annual growth rate (CAGR), from $35M to $37M.
What does stock issuance proceeds mean?
Cash received from issuing common stock — IPOs, secondary offerings, DRIP, employee stock purchase plans, and option exercises.

Ask your AI about Centene's stock issuance proceeds.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude